Tom Beauvironnet

Tom started his career as a pharmacist for about two years. He was involved in a clinical trial department in a University Hospital. He then joined the pharmaceutical industry, joining Osivax, a biotechnology startup developing a flu vaccine candidate. He has been involved during their transition from preclinical to clinical phases at a crossroads between business development and quality insurance. He arrived in the healthcare venture capital industry in 2019 as an investment manager for Crédit Mutuel Innovation.

Tom joined Karista in 2021 and is mainly looking at Healthcare and Digital Health ventures.

Tom holds a pharmacy degree and is a graduate of emlyon Business School.